Lurbinectedin-Induced Tumor Lysis Syndrome in Small Cell Neuroendocrine Cancer of the Cecum: A First-Ever Case Report

Patient: Female, 38-year-old Final Diagnosis: Tumor lysis syndrome Symptoms: Abdominal pain Medication:— Clinical Procedure: — Specialty: Hematology • Oncology OBJECTIVE: Unusual clinical course BACKGROUND: Lurbinectedin (Lurbi) was first approved in June 2020 for metastatic small cell lung cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahab, Ahsan, Rafae, Abdul, Mushtaq, Kamran, Venkata, Krishna, Sarmad, Rehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212840/
https://www.ncbi.nlm.nih.gov/pubmed/34125741
http://dx.doi.org/10.12659/AJCR.932081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212840/
https://www.ncbi.nlm.nih.gov/pubmed/34125741
http://dx.doi.org/10.12659/AJCR.932081

Ejemplares similares